MoneyWorks4Me

Supriya Lifescience informs about transcript of earnings call

20 Feb 2023 Evaluate

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Supriya Lifescience has informed that it enclosed the transcript of the Earnings call held on Wednesday, February 15, 2023, at 11.00 am IST to discuss operational and financial performance of the Company for the quarter and nine month ended December 31, 2022.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..